Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 4 | Cancer Cell International

Fig. 4

From: Collapsin response mediator protein 4 promotor methylation level as a potential predictor for diagnosing primary malignant lymphoma of the prostate

Fig. 4

Quantitative pyrosequencing of methylation sites within CRMP4 promoter region. The CRMP4 gene promoter region A S1 (methylation sites − 848 and − 841) and region B S2 (methylation sites − 680, − 678, − 674, − 671, − 665, − 660, and − 658) was significantly methylated, and the methylation of site S3–S6 was not significant

Back to article page